In vivo acquisition of high-level resistance to imipenem in Escherichia coli
about
Carbapenem-Resistant Bacteria Recovered from Faeces of Dairy Cattle in the High Plains Region of the USAEmergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.Characterization of a novel AmpC β-lactamase produced by a carbapenem-resistant Cedecea davisae clinical isolate.Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial DominanceAntimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance ProgramAntibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.Host-Specific Patterns of Genetic Diversity among IncI1-Iγ and IncK Plasmids Encoding CMY-2 β-Lactamase in Escherichia coli Isolates from Humans, Poultry Meat, Poultry, and Dogs in DenmarkThe role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study.Integron mobilization unit as a source of mobility of antibiotic resistance genes.Ertapenem resistance of Escherichia coli.Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1-type AmpC beta-lactamases in Korean respiratory isolates of Klebsiella pneumoniae.Emergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum beta-lactamase AmpC.Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).A pharmacokinetic-pharmacodynamic model characterizing the emergence of resistant Escherichia coli subpopulations during ertapenem exposure.Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China.Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae.Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.Tigecycline activity against metallo-β-lactamase-producing bacteria.Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China.Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in ChinaStructural Alteration of OmpR as a Source of Ertapenem Resistance in a CTX-M-15-Producing Escherichia coli O25b:H4 Sequence Type 131 Clinical Isolate.Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases.Sensitive and specific phenotypic assay for metallo-beta-lactamase detection in Enterobacteria by use of a moxalactam disk supplemented with EDTA.CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli.Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.Stress-Adaptive Responses Associated with High-Level Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae.Multidrug-Resistant Escherichia albertii: Co-occurrence of β-Lactamase and MCR-1 Encoding Genes.
P2860
Q28552964-E8669BB4-3610-45EC-AA6D-727E12749545Q33556074-475860C9-3293-495D-9D77-250426809944Q34596825-1274A686-461D-4089-8144-444ED29A75B4Q34641507-DD0207FF-E6BD-4115-8579-435700E3C2C3Q35071905-BB2C9622-C780-4454-920F-23142D734F7CQ35607909-8D657BB0-AE42-458D-AE97-6E7DF6147437Q36076066-95EC0306-A7FC-42D5-B42A-BC18D9941701Q36425049-E22DAF46-2F30-42E3-90D0-3BA0E39C810FQ37036659-30FB6513-D1FB-4FB0-A609-06910897E865Q37173645-D9EAB4FD-C9D2-42CC-8DF1-BAB1BB071331Q37184911-D6AE44D7-895C-4C89-8A9C-57F08B572CA7Q37204188-7A91B7B7-9935-43A8-BF47-2DF4C78BE08FQ37302659-CD41E47E-B73B-4AC0-B7BF-B96CB29B56B4Q37425843-95691EFF-7AFC-4804-93A9-68A191F56F3CQ38282628-9C7338CA-ECFB-4693-8AB1-D605EF6623DCQ38624963-28E8C951-0EF0-41B8-8286-BCFF0585B6BAQ39665401-4DEF81EB-3D15-413B-9958-571DB81AF6CAQ39766377-BA566F93-6B09-4122-8AD1-E45F29A473CDQ39956534-3DB316E4-1F04-4EFD-BFCA-9BF7E87AF3F8Q40729625-34B82847-D609-4163-A886-D17FD4A6FB7FQ40750806-F306BE7E-4619-4B5E-8EEA-A05025919721Q40945550-3226C9BD-DF79-4830-8EA2-D5C99C535A0CQ41860185-02A4EBB9-DC5F-4D93-93FC-440A056CA3AFQ41907702-B2074031-8487-48A8-B67C-7FF71586185CQ41995038-C370C16E-9E95-4715-8102-FD4A42A6927BQ42358844-CBEA2BD2-04AF-4A8B-84BE-4C0C4FD0CCE0Q42375906-C8A9064E-91A7-47C9-B046-77FEB0B9049FQ42850188-DB31AEC8-CF00-4F45-8CA7-248F978AFC29Q43194349-3AAE1183-FFD0-4F06-B777-C850D20428E6Q44904821-E43032F0-3A86-4AE4-A056-56B6D8D13CF5Q52320817-CE19B5E0-CEC2-49BE-BCBC-0C3CE0FBBAF2Q52674855-EEEFFB38-F1A9-4F81-A291-676C71269D4E
P2860
In vivo acquisition of high-level resistance to imipenem in Escherichia coli
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo acquisition of high-level resistance to imipenem in Escherichia coli
@en
In vivo acquisition of high-level resistance to imipenem in Escherichia coli.
@nl
type
label
In vivo acquisition of high-level resistance to imipenem in Escherichia coli
@en
In vivo acquisition of high-level resistance to imipenem in Escherichia coli.
@nl
prefLabel
In vivo acquisition of high-level resistance to imipenem in Escherichia coli
@en
In vivo acquisition of high-level resistance to imipenem in Escherichia coli.
@nl
P2860
P1476
In vivo acquisition of high-level resistance to imipenem in Escherichia coli
@en
P2093
Claire Héritier
Colette Spicq
P2860
P304
P356
10.1128/JCM.42.8.3831-3833.2004
P407
P577
2004-08-01T00:00:00Z